Vitamin B12 and Heart Health

  • , by SANUSq Research team
  • 9 min reading time
Vitamin b12 in heart health

Vitamin B12's link to heart health runs through a lesser-known molecule called homocysteine — and the story has an instructive twist.

Meet homocysteine

Homocysteine is an amino acid your body produces normally, and then clears away using B vitamins — chiefly B12, folate (B9) and B6. When those vitamins run low, homocysteine can build up. That matters because observational studies have consistently found that higher blood homocysteine is associated with a higher risk of heart disease and stroke. On paper, this made a tidy hypothesis: lower homocysteine with B vitamins, and you should lower heart-disease risk.

B vitamins, particularly folate and B12, reliably lower blood homocysteine levels — folic acid alone reduces it by around a quarter, with B12 adding a further reduction (homocysteine-lowering meta-analysis, 2000).

How B12 and homocysteine are connected

The link between B12 and homocysteine is a specific piece of biochemistry rather than a vague association, which is part of why the hypothesis looked so persuasive. Homocysteine sits at a junction in the body's handling of methionine, an amino acid from protein in the diet. From that junction it can go two ways. It can be recycled back into methionine, a reaction in which vitamin B12 acts as the cofactor for the enzyme doing the work while folate supplies the methyl group being transferred. Or it can be diverted down a separate route and converted onwards to cysteine, a pathway that depends on vitamin B6.

That is why three different B vitamins turn up in the same story, and why a shortage of any of them can let homocysteine accumulate. It is also why supplying them lowers it so reliably: you are restoring the traffic flow at a junction, and the measurement responds. The mechanism is real, well mapped and not in dispute. What was in dispute was what the falling number would mean.

The instructive twist

Here's where science did its job and tested the tidy hypothesis — with humbling results.

Major randomised trials (including HOPE-2 and NORVIT) and later reviews found that although B vitamins effectively lower homocysteine, this does not translate into fewer heart attacks or cardiovascular deaths in high-risk patients (homocysteine and cardiovascular review, 2025).

In other words, homocysteine looks more like a marker that travels alongside heart-disease risk than a direct cause you can treat your way out of with vitamins. It's a classic reminder that lowering a risk marker doesn't automatically lower the risk itself. Some analyses do hint at a small reduction in stroke risk, but the headline is that B vitamins are not a proven way to prevent heart disease.

What the vitamin B12 heart health story teaches

The vitamin B12 heart health story is one of the clearest teaching cases in nutrition, and its lesson generalises well beyond B vitamins.

The reasoning that failed was not sloppy. There was a consistent association, a plausible mechanism, and an intervention that reliably moved the marker in the right direction. That chain still turned out to be broken somewhere, and there are only a few places it can break. A marker can be a bystander — produced by the same conditions that cause the disease without contributing to it. It can be a consequence rather than a cause, since impaired kidney function raises homocysteine and also raises cardiovascular risk. Or the association can be carried by the company the marker keeps: people with higher homocysteine tend to differ in age, diet, smoking and kidney function, and observational studies can never fully separate those threads.

Randomised trials exist precisely to settle that question, and here they did. The useful habit to take away is to ask, whenever a supplement is recommended on the strength of a marker, whether anyone has tested the outcome that actually matters — and to notice when the answer is no.

So where does B12 fit?

None of this diminishes B12's genuine importance. It remains essential for healthy nerves, red blood cells and DNA, and correcting a true B12 deficiency is absolutely worthwhile — especially for the groups most at risk, as we cover in food sources of vitamin B12. The honest, specific point is narrower: taking B12 for the sole purpose of preventing heart disease by lowering homocysteine isn't supported by the trial evidence. For heart health, the bigger levers are the familiar ones — not smoking, staying active, managing blood pressure, and the anti-inflammatory eating we describe in how to reduce inflammation naturally.

Who is most likely to be short of B12

Since correcting a real deficiency is the part that genuinely matters, it is worth knowing who is most likely to have one. B12 occurs naturally only in animal foods and in fortified products, so people eating a vegan diet, and to a lesser extent a vegetarian one, need a reliable source. Absorption is the other common problem: B12 has to be released from food by stomach acid and then bound to a carrier protein made in the stomach before it can be taken up in the last part of the small intestine, so anything that disrupts that chain matters. That includes the reduced stomach acid common with ageing, pernicious anaemia, coeliac disease and other conditions affecting the gut, and surgery involving the stomach or the ileum. Some long-term medicines, including metformin and acid-suppressing drugs, are associated with lower B12 levels, which is something a doctor can monitor.

Deficiency tends to announce itself vaguely: tiredness, a sore or smooth tongue, pins and needles or numbness, unsteadiness, low mood or difficulty concentrating. Two points are worth holding onto. It can be tested for, so guessing is unnecessary. And because folate can correct the blood changes of B12 deficiency while leaving the nerve problem untreated, a shortfall should be identified properly rather than papered over — nerve damage left long enough may not fully recover.

Frequently asked questions

Does vitamin B12 protect your heart?

B12 (with folate) lowers homocysteine, a marker linked with heart disease. However, trials show that lowering homocysteine with B vitamins does not reduce heart attacks or cardiovascular deaths, so B12 isn't a proven heart-disease preventive.

What is homocysteine?

It's an amino acid the body makes and normally clears using B12, folate and B6. When these are low, homocysteine can rise, and higher levels are associated with cardiovascular risk in observational studies.

If B vitamins lower homocysteine, why don't they prevent heart attacks?

Because homocysteine appears to be more a marker that accompanies risk than a direct cause. Lowering it with vitamins doesn't lower the underlying risk — a reminder that changing a marker isn't the same as changing outcomes.

Is it still worth correcting a B12 deficiency?

Yes, definitely. B12 is essential for nerves, blood and DNA, and correcting a true deficiency is important for those affected — just not as a strategy specifically to prevent heart disease.

Should I take vitamin B12 for heart disease?

Taking vitamin B12 for heart disease prevention specifically is not supported by the trial evidence, which found no reduction in heart attacks or cardiovascular deaths despite homocysteine falling. Taking it to correct a genuine deficiency is a different question, and a worthwhile one.

Who is most at risk of low B12?

People eating a vegan or largely vegetarian diet, older adults, anyone with pernicious anaemia or a gut condition affecting absorption, those who have had stomach or bowel surgery, and people on some long-term medicines. A blood test settles it rather than guesswork.

What actually helps prevent heart disease?

The well-established levers are not smoking, regular activity, managing blood pressure and weight, and an anti-inflammatory, plant-rich diet — alongside any care your doctor advises.

References

  1. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost. 2000;26(3):341–8. PMID 11011852
  2. D'Elia S, Morello M, Titolo G, et al. Homocysteine in the Cardiovascular Setting: What to Know, What to Do, and What Not to Do. J Cardiovasc Dev Dis. 2025;12(10):383. PMC12564181

Read more on the blog

Watch on YouTube

Explore more on our channel, @SANUSqHealthSupplements.

We wish you good health on your terms.
The team at SANUSq.

PS. Curious what's currently on offer? Take a look at our latest promotions.

The health information in this article is provided for educational purposes only. Consult your healthcare professional before making any medical decisions.

Regulatory Notice

The information on our websites, blogs, and emails is provided for informational purposes only and has not been evaluated by the EMA, EFSA, or FDA. It is not intended to replace medical advice provided by your healthcare professional, and is not intended to diagnose, treat, cure, or prevent any disease. Our products are intended for adults aged 18 and over. While the vitamins and supplements mentioned may offer various health benefits, supplements and dietary changes should be considered part of an overall health plan and not a substitute for professional medical treatment. Only a qualified healthcare professional can provide personalized advice and treatment plans based on your individual health needs and medical history; you should consult your healthcare professional before taking any product(s) if you are pregnant or breastfeeding.

Tags


SANUSq Health logo

© 2026 SANUSq Health, Powered by Shopify

    Login

    Forgot your password?

    Don't have an account yet?
    Create account